Exemplos de uso de Gemzar em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Gemzar 1000 mg contains.
How to store Gemzar 6.
Gemzar 200 mg powder for solution for infusion.
Take special care with Gemzar.
Each pack of Gemzar contains 1 vial.
You must discontinue breast-feeding during Gemzar treatment.
It is marketed as Gemzar by Eli Lilly and Company.
Gemzar belongs to a group of medicines called“cytotoxics”.
Side effects with Gemzar may include.
Particular attention was given to the therapeutic indications of Gemzar.
Gemzar 1000 mg contains 17.5 mg(< 1 mmol) sodium per vial.
The following indications are currently approved for Gemzar and were assessed by the CHMP.
Gemzar 1000 mg powder for solution for infusion Gemcitabine.
If you are allergic(hypersensitive) to gemcitabine orany of the other ingredients of Gemzar.
Sodium Gemzar 200 mg contains 3.5 mg(< 1 mmol) sodium per vial.
Men are advised not to father a child during andup to 6 months following treatment with Gemzar.
Gemzar is a white to off-white powder, for solution for infusion in a vial.
The CHMP therefore adopted the remaining five indications for Gemzar, as worded in the revised SPC.
Driving and using machines Gemzar may make you feel sleepy, particularly if you have consumed any alcohol.
The CHMP gave a positive opinion on 26 June 2008 recommending the harmonisation of the SPC, Labelling andPackage Leaflet including quality aspects for Gemzar.
The usual dose of Gemzar is 1000-1250 mg for every square metre of your body's surface area.
The CHMP has recommended the amendment of the Marketing Authorisations for which the Summary of Product Characteristics, labelling andpackage leaflet are set out in Annex III for Gemzar.
Gemzar 200 mg powder for solution for infusion Gemzar 1000 mg powder for solution for infusion Gemcitabine.
Important information about some of the ingredients of Gemzar Gemzar contains 3.5 mg(< 1 mmol) of sodium in each 200 mg vial and 17.5 mg(< 1 mmol) sodium in each 1000 mg vial.
Gemzar may be given alone or in combination with other anti-cancer medicines, depending on the type of cancer.
As no studies were available to support the use of gemcitabine as single agent neither in first or second line,the CHMP requested the MAH to further discuss the indication of Gemzar in ovarian cancer.
How frequently you receive your Gemzar infusion depends on the type of cancer that you are being treated for.
On 8 June 2007, the European Commission presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, as amended, in order to harmonise the nationally authorised Summaries of Product Characteristics(SPC),Labelling and Package Leaflet including quality aspects of the medicinal product Gemzar.
Gemcitabine(Gemzar): Ribonucleotide reductase is inhibited and it fights with deoxycytidine triphosphate to fit itself into the DNA.
The basis for referral was that there were divergences in the Summaries of Product Characteristics(SPC)including quality aspects of Gemzar approved across EU Member States, mainly with respect to the approved indications, the posology, the contra-indications and the warnings.